Insider Trading May 29, 2026 03:46 PM

Director Sale at Chemed Corp Follows Strong Quarterly Performance and Board Developments

Analysis of George J. Walsh's transaction and recent corporate milestones provide insight into company valuation.

By Derek Hwang CHE

George J. Walsh III, a director at CHEMED CORP, reported selling shares on May 29, 2026. This transaction occurred against a backdrop of positive financial reporting for the first quarter of 2026, where Chemed exceeded analyst expectations for both earnings and revenue. Furthermore, recent shareholder meetings saw key corporate actions, including the election of all board nominees.

Director Sale at Chemed Corp Follows Strong Quarterly Performance and Board Developments
CHE

Key Points

  • The sale of shares by director George J. Walsh III occurred following a period of strong corporate performance.
  • Chemed reported Q1 2026 earnings per share of $5.65, beating estimates, while revenue reached $657.5 million against an expected $651.02 million.
  • The company demonstrated shareholder commitment through maintaining dividends for 56 years and increasing them for 17 consecutive years.

George J. Walsh III, who serves as a director at CHEMED CORP (NYSE:CHE), filed an SEC report detailing his sale of company stock on May 29, 2026.

According to the filing, Mr. Walsh disposed of 500 shares of CHEMED’s Capital Stock. The transaction was executed at a price point of $437.83 per share, resulting in total proceeds valued at $218,915. Notably, this sale price slightly exceeded the stock's observable trading level of $432.20. Market data from InvestingPro suggests that, relative to its Fair Value estimate, the stock may currently be undervalued.

Following the disposal of these shares, Mr. Walsh maintains a direct holding of 3,209 shares of CHEMED Capital Stock. His indirect holdings are managed through his spouse, who holds an additional 434 shares. The company's history reveals a sustained commitment to its shareholders, evidenced by maintaining dividend payments for 56 consecutive years and increasing that dividend for the past 17 straight years.

The recent corporate developments at Chemed Corporation suggest strong underlying financial health and operational stability. For the first quarter of 2026, the company released robust financial results that surpassed expectations set by analysts. CHEMED reported earnings per share (EPS) of $5.65, which was higher than the forecasted figure of $5.34. Furthermore, revenue also outperformed projections, reaching a total of $657.5 million when compared to the anticipated $651.02 million.

These positive results prompted an adjustment from RBC Capital, which subsequently raised its price target for Chemed stock to $436, up from its previous valuation of $422. The firm maintained a rating of Sector Perform on the equity.

In addition to the financial performance, Chemed held its annual meeting of stockholders. During this gathering, all eight nominees put forward for the board of directors were successfully elected by the shareholders. Shareholders also voted to ratify the independent auditor. However, the company received a rejection during the advisory vote concerning executive compensation.

These various developments - including strong earnings reports and key governance actions - collectively point toward the company's solid financial trajectory and strategic decision-making process. The combination of consistent dividend history and recent outperformance suggests continued stability within the corporation.

Risks

  • The advisory vote on executive compensation was rejected by shareholders at the annual meeting, indicating a potential point of internal disagreement regarding management pay structures.
  • While the stock traded slightly below its director's sale price ($432.20 vs $437.83), market data suggests it may still be undervalued compared to its Fair Value estimate.

More from Insider Trading

TWFG Director Michael Doak Accumulates $638K in Shares Amid Stock Decline Jun 4, 2026 FormFactor Director Sheri Rhodes Offloads $793K in Equity Amid Strong Quarterly Performance Jun 4, 2026 Zoom CEO Eric Yuan Executes $2.64 Million Share Sales Under Pre-Arranged Trading Plan Jun 4, 2026 Enphase Director Richard Mora Offloads Shares Amid Sector Activity Jun 4, 2026 Datadog CRO Sean Walters Disposes of $3.58M in Equity Ahead of Fiscal Cycle Shift Jun 4, 2026